Pain Management Therapeutics Market Size - Global Industry, Share, Analysis, Trends and Forecast 2023 - 2032
CHAPTER 1. Industry Overview of Pain Management Therapeutics Market
1.1. Definition and Scope
1.1.1. Definition of Pain Management Therapeutics
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Pain Management Therapeutics Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Pain Management Therapeutics Market By Drug Class
1.2.3. Pain Management Therapeutics Market By Indication
1.2.4. Pain Management Therapeutics Market By Distribution Channel
1.2.5. Pain Management Therapeutics Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Source
2.2.2. Primary Source
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Pain Management Therapeutics Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Pain Management Therapeutics Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Price Trend of Key Raw Material
3.8.1. Raw Material Suppliers
3.8.2. Proportion of Manufacturing Cost Structure
3.8.2.1. Raw Material
3.8.2.2. Labor Cost
3.8.2.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2022
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022
4.2. R&D Status of Major Manufacturers in 2022
CHAPTER 5. Pain Management Therapeutics Market By Drug Class
5.1. Introduction
5.2. Pain Management Therapeutics Revenue By Drug Class
5.2.1. Pain Management Therapeutics Revenue (USD Billion) and Forecast, By Drug Class, 2020-2032
5.2.2. NSAIDs
5.2.2.1. NSAIDs Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3. Anticonvulsants
5.2.3.1. Anticonvulsants Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.4. Opioids
5.2.4.1. Opioids Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.5. Antidepressants
5.2.5.1. Antidepressants Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.6. Anesthetics
5.2.6.1. Anesthetics Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.7. Others
5.2.7.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 6. Pain Management Therapeutics Market By Indication
6.1. Introduction
6.2. Pain Management Therapeutics Revenue By Indication
6.2.1. Pain Management Therapeutics Revenue (USD Billion) and Forecast, By Indication, 2020-2032
6.2.2. Arthritic Pain
6.2.2.1. Arthritic Pain Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3. Post-Operative Pain
6.2.3.1. Post-Operative Pain Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.4. Neuropathic Pain
6.2.4.1. Neuropathic Pain Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.5. Cancer Pain
6.2.5.1. Cancer Pain Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.6. Chronic Back Pain
6.2.6.1. Chronic Back Pain Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.7. Others
6.2.7.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 7. Pain Management Therapeutics Market By Distribution Channel
7.1. Introduction
7.2. Pain Management Therapeutics Revenue By Distribution Channel
7.2.1. Pain Management Therapeutics Revenue (USD Billion) and Forecast, By Distribution Channel, 2020-2032
7.2.2. Online Pharmacy
7.2.2.1. Online Pharmacy Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.3. Hospital Pharmacy
7.2.3.1. Hospital Pharmacy Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.4. Retail Pharmacy
7.2.4.1. Retail Pharmacy Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 8. North America Pain Management Therapeutics Market By Country
8.1. North America Pain Management Therapeutics Market Overview
8.2. U.S.
8.2.1. U.S. Pain Management Therapeutics Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
8.2.2. U.S. Pain Management Therapeutics Revenue (USD Billion) and Forecast By Indication, 2020-2032
8.2.3. U.S. Pain Management Therapeutics Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
8.3. Canada
8.3.1. Canada Pain Management Therapeutics Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
8.3.2. Canada Pain Management Therapeutics Revenue (USD Billion) and Forecast By Indication, 2020-2032
8.3.3. Canada Pain Management Therapeutics Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
8.4. North America PEST Analysis
CHAPTER 9. Europe Pain Management Therapeutics Market By Country
9.1. Europe Pain Management Therapeutics Market Overview
9.2. U.K.
9.2.1. U.K. Pain Management Therapeutics Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
9.2.2. U.K. Pain Management Therapeutics Revenue (USD Billion) and Forecast By Indication, 2020-2032
9.2.3. U.K. Pain Management Therapeutics Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
9.3. Germany
9.3.1. Germany Pain Management Therapeutics Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
9.3.2. Germany Pain Management Therapeutics Revenue (USD Billion) and Forecast By Indication, 2020-2032
9.3.3. Germany Pain Management Therapeutics Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
9.4. France
9.4.1. France Pain Management Therapeutics Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
9.4.2. France Pain Management Therapeutics Revenue (USD Billion) and Forecast By Indication, 2020-2032
9.4.3. France Pain Management Therapeutics Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
9.5. Spain
9.5.1. Spain Pain Management Therapeutics Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
9.5.2. Spain Pain Management Therapeutics Revenue (USD Billion) and Forecast By Indication, 2020-2032
9.5.3. Spain Pain Management Therapeutics Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
9.6. Rest of Europe
9.6.1. Rest of Europe Pain Management Therapeutics Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
9.6.2. Rest of Europe Pain Management Therapeutics Revenue (USD Billion) and Forecast By Indication, 2020-2032
9.6.3. Rest of Europe Pain Management Therapeutics Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
9.7. Europe PEST Analysis
CHAPTER 10. Asia Pacific Pain Management Therapeutics Market By Country
10.1. Asia Pacific Pain Management Therapeutics Market Overview
10.2. China
10.2.1. China Pain Management Therapeutics Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
10.2.2. China Pain Management Therapeutics Revenue (USD Billion) and Forecast By Indication, 2020-2032
10.2.3. China Pain Management Therapeutics Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
10.3. Japan
10.3.1. Japan Pain Management Therapeutics Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
10.3.2. Japan Pain Management Therapeutics Revenue (USD Billion) and Forecast By Indication, 2020-2032
10.3.3. Japan Pain Management Therapeutics Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
10.4. India
10.4.1. India Pain Management Therapeutics Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
10.4.2. India Pain Management Therapeutics Revenue (USD Billion) and Forecast By Indication, 2020-2032
10.4.3. India Pain Management Therapeutics Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
10.5. Australia
10.5.1. Australia Pain Management Therapeutics Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
10.5.2. Australia Pain Management Therapeutics Revenue (USD Billion) and Forecast By Indication, 2020-2032
10.5.3. Australia Pain Management Therapeutics Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
10.6. South Korea
10.6.1. South Korea Pain Management Therapeutics Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
10.6.2. South Korea Pain Management Therapeutics Revenue (USD Billion) and Forecast By Indication, 2020-2032
10.6.3. South Korea Pain Management Therapeutics Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific Pain Management Therapeutics Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
10.7.2. Rest of Asia-Pacific Pain Management Therapeutics Revenue (USD Billion) and Forecast By Indication, 2020-2032
10.7.3. Rest of Asia-Pacific Pain Management Therapeutics Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
10.8. Asia Pacific PEST Analysis
CHAPTER 11. Latin America Pain Management Therapeutics Market By Country
11.1. Latin America Pain Management Therapeutics Market Overview
11.2. Brazil
11.2.1. Brazil Pain Management Therapeutics Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
11.2.2. Brazil Pain Management Therapeutics Revenue (USD Billion) and Forecast By Indication, 2020-2032
11.2.3. Brazil Pain Management Therapeutics Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
11.3. Mexico
11.3.1. Mexico Pain Management Therapeutics Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
11.3.2. Mexico Pain Management Therapeutics Revenue (USD Billion) and Forecast By Indication, 2020-2032
11.3.3. Mexico Pain Management Therapeutics Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
11.4. Rest of Latin America
11.4.1. Rest of Latin America Pain Management Therapeutics Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
11.4.2. Rest of Latin America Pain Management Therapeutics Revenue (USD Billion) and Forecast By Indication, 2020-2032
11.4.3. Rest of Latin America Pain Management Therapeutics Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
11.5. Latin America PEST Analysis
CHAPTER 12. Middle East & Africa Pain Management Therapeutics Market By Country
12.1. Middle East & Africa Pain Management Therapeutics Market Overview
12.2. GCC
12.2.1. GCC Pain Management Therapeutics Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
12.2.2. GCC Pain Management Therapeutics Revenue (USD Billion) and Forecast By Indication, 2020-2032
12.2.3. GCC Pain Management Therapeutics Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
12.3. South Africa
12.3.1. South Africa Pain Management Therapeutics Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
12.3.2. South Africa Pain Management Therapeutics Revenue (USD Billion) and Forecast By Indication, 2020-2032
12.3.3. South Africa Pain Management Therapeutics Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa Pain Management Therapeutics Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
12.4.2. Rest of Middle East & Africa Pain Management Therapeutics Revenue (USD Billion) and Forecast By Indication, 2020-2032
12.4.3. Rest of Middle East & Africa Pain Management Therapeutics Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
12.5. Middle East & Africa PEST Analysis
CHAPTER 13. Player Analysis Of Pain Management Therapeutics Market
13.1. Pain Management Therapeutics Market Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking Of Key Players By Price, Presence, Market Share, And R&D Investment
13.2.2. New Product Launches and Product Enhancements
13.2.3. Mergers And Acquisition In Global Pain Management Therapeutics Market
13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 14. Company Profile
14.1. Pfizer Inc.
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (USD Billion), 2022
14.1.3.2. Pfizer Inc. 2022 Pain Management Therapeutics Business Regional Distribution
14.1.4. Product /Service and Specification
14.1.5. Recent Developments & Business Strategy
14.2. AbbVie Inc.
14.3. Novartis AG
14.4. Johnson & Johnson
14.5. Eli Lilly and Company
14.6. GlaxoSmithKline plc
14.7. Merck & Co., Inc.
14.8. Sanofi S.A.
14.9. AstraZeneca plc
14.10. Teva Pharmaceutical Industries Ltd.
14.11. Endo International plc
14.12. Mallinckrodt Pharmaceuticals
Frequently Asked Questions
What was the market size of the global pain management therapeutics in 2022?
The market size of pain management therapeutics was USD 75.3 Billion in 2022.
What is the CAGR of the global pain management therapeutics market from 2023 to 2032?
The CAGR of pain management therapeutics is 4.4% during the analysis period of 2023 to 2032.
Which are the key players in the pain management therapeutics market?
The key players operating in the global market are including Pfizer Inc., AbbVie Inc., Novartis AG, Johnson & Johnson, Eli Lilly and Company, GlaxoSmithKline plc, Merck & Co., Inc., Sanofi S.A., AstraZeneca plc, Teva Pharmaceutical Industries Ltd., Endo International plc, and Mallinckrodt Pharmaceuticals.
Which region dominated the global pain management therapeutics market share?
North America held the dominating position in pain management therapeutics industry during the analysis period of 2023 to 2032.
Which region registered fastest CAGR from 2023 to 2032?
Asia-Pacific region exhibited fastest growing CAGR for market of pain management therapeutics during the analysis period of 2023 to 2032.
What are the current trends and dynamics in the global pain management therapeutics industry?
The current trends and dynamics in the pain management therapeutics industry include increasing prevalence of chronic pain conditions, and growing demand for non-opioid pain management options.
Which drug class held the maximum share in 2022?
The NSAIDs drug class held the maximum share of the pain management therapeutics industry.
Select Licence Type
Connect with our sales team
Why Acumen Research and Consulting
100%
Customer Satisfaction
24x7+
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
